LOADING

Type to search

Author: Nick Paul

ipsen-names-sanofi-pasteur-ceo-loew-as-new-leader
puretech-eyes-clinical-trial-in-long-term-covid-19-complications
ngos-slam-‘extremely-dubious-priorities’-of-eu-r&d-program
argenx’s-autoimmune-phase-3-hits-goals,-teeing-up-fda-filing
merck-inks-themis-buyout-to-join-covid-19-vaccine-race
genentech-posts-long-term-data-on-near-approval-soliris-rival
astrazeneca’s-covid-19-vaccine-enters-phase-2/3-clinical-trial
sr-one-fuels-hotspot’s-$65m-b-round-to-fund-allosteric-r&d
gilead’s-filgotinib-phase-3-hits-primary-endpoint-but-details-dampen-hopes
atea-raises-$215m-to-support-midphase-covid-19-antiviral-trial